North America Radiodermatitis Market Size & Outlook
North America radiodermatitis market, 2018-2030 (US$M)
Related Markets
North America radiodermatitis market highlights
- The North America radiodermatitis market generated a revenue of USD 115.8 million in 2023.
- The market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2023.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 115.8 million |
| Market revenue in 2030 | USD 151.7 million |
| Growth rate | 3.9% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, North America region accounted for 28.6% of the global radiodermatitis market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 246.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 74.7% in 2023. Horizon Databook has segmented the North America radiodermatitis market based on topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
In 2016, North America captured second largest share of the market. Consistent number of collaborations encouraged by key market players for increasing their R&D capabilities is presumed to be responsible for the considerable share captured by this region.
Moreover, presence of key market players in this region who undertake strategic initiatives such as new product launches and merger & acquisitions is expected to make this a lucrative segment by signaling tremendous potential.
In January 2017, Derma Sciences purchased MEDIHONEY brand from Comvita Limited based in New Zealand with a view to increase its Advanced Radiodermatitis product portfolio, as a result of which new products are available in this region.
Reasons to subscribe to North America radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America radiodermatitis market , including forecasts for subscribers. This continent databook contains high-level insights into North America radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America radiodermatitis market size, by country, 2018-2030 (US$M)
North America Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
